Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3012% below fair value
$0.95+0.06 (+7.26%)
Close on Nov 18, 2026Market cap $94.80MP/E –Yield –
Stereotaxis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Stereotaxis's revenue for the twelve months ending Jun 30, 2026 was $30.07M, down 5.5% year over year. For fiscal 2025 it was $32.38M, up 20.3% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is $54.05M in fiscal 2010.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.38M | +20.3% |
| FY2024 | Dec 31, 2024 | $26.92M | +0.5% |
| FY2023 | Dec 31, 2023 | $26.77M | -4.9% |
| FY2022 | Dec 31, 2022 | $28.15M | -19.6% |
| FY2021 | Dec 31, 2021 | $35.02M | +31.5% |
| FY2020 | Dec 31, 2020 | $26.63M | -7.9% |
| FY2019 | Dec 31, 2019 | $28.90M | -1.5% |
| FY2018 | Dec 31, 2018 | $29.35M | -5.8% |
| FY2017 | Dec 31, 2017 | $31.14M | -3.2% |
| FY2016 | Dec 31, 2016 | $32.16M | -14.6% |
| FY2015 | Dec 31, 2015 | $37.67M | +7.6% |
| FY2014 | Dec 31, 2014 | $35.01M | -7.9% |
| FY2013 | Dec 31, 2013 | $38.03M | -18.3% |
| FY2012 | Dec 31, 2012 | $46.56M | +10.9% |
| FY2011 | Dec 31, 2011 | $41.99M | -22.3% |
| FY2010 | Dec 31, 2010 | $54.05M | +5.7% |
| FY2009 | Dec 31, 2009 | $51.15M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.67M | -12.8% |
| Q1 FY2026 | Mar 31, 2026 | $6.29M | -15.8% |
| Q4 FY2025 | Dec 31, 2025 | $8.64M | +36.3% |
| Q3 FY2025 | Sep 30, 2025 | $7.46M | -18.8% |
| Q2 FY2025 | Jun 30, 2025 | $8.80M | +95.4% |
| Q1 FY2025 | Mar 31, 2025 | $7.47M | +8.6% |
| Q4 FY2024 | Dec 31, 2024 | $6.34M | +38.9% |
| Q3 FY2024 | Sep 30, 2024 | $9.20M | +17.9% |
| Q2 FY2024 | Jun 30, 2024 | $4.50M | -42.7% |
| Q1 FY2024 | Mar 31, 2024 | $6.88M | +5.1% |
| Q4 FY2023 | Dec 31, 2023 | $4.57M | -37.5% |
| Q3 FY2023 | Sep 30, 2023 | $7.80M | +1.9% |
| Q2 FY2023 | Jun 30, 2023 | $7.86M | +27.7% |
| Q1 FY2023 | Mar 31, 2023 | $6.55M | -6.9% |
| Q4 FY2022 | Dec 31, 2022 | $7.30M | -11.4% |
| Q3 FY2022 | Sep 30, 2022 | $7.66M | -15.9% |
| Q2 FY2022 | Jun 30, 2022 | $6.15M | -32.0% |
| Q1 FY2022 | Mar 31, 2022 | $7.04M | -18.4% |
| Q4 FY2021 | Dec 31, 2021 | $8.24M | +20.8% |
| Q3 FY2021 | Sep 30, 2021 | $9.11M | +4.6% |
| Q2 FY2021 | Jun 30, 2021 | $9.05M | +69.3% |
| Q1 FY2021 | Mar 31, 2021 | $8.62M | +49.8% |
| Q4 FY2020 | Dec 31, 2020 | $6.82M | -1.0% |
| Q3 FY2020 | Sep 30, 2020 | $8.70M | +6.1% |
| Q2 FY2020 | Jun 30, 2020 | $5.35M | -21.4% |
| Q1 FY2020 | Mar 31, 2020 | $5.76M | -17.9% |
| Q4 FY2019 | Dec 31, 2019 | $6.89M | -5.2% |
| Q3 FY2019 | Sep 30, 2019 | $8.20M | +8.6% |
| Q2 FY2019 | Jun 30, 2019 | $6.80M | -10.0% |
| Q1 FY2019 | Mar 31, 2019 | $7.01M | +0.5% |
| Q4 FY2018 | Dec 31, 2018 | $7.27M | -3.8% |
| Q3 FY2018 | Sep 30, 2018 | $7.56M | -7.2% |
| Q2 FY2018 | Jun 30, 2018 | $7.55M | -10.8% |
| Q1 FY2018 | Mar 31, 2018 | $6.97M | -0.1% |
| Q4 FY2017 | Dec 31, 2017 | $7.56M | +3.4% |
| Q3 FY2017 | Sep 30, 2017 | $8.14M | -2.3% |
| Q2 FY2017 | Jun 30, 2017 | $8.47M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.31M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.33M | – |
See a number that looks wrong?